State Of Wyoming Vericel Corp Transaction History

State Of Wyoming

$778 Million
Q2 2025

A detailed history of State Of Wyoming transactions in Vericel Corp stock. As of the latest transaction made, State Of Wyoming holds 5,128 shares of VCEL stock, worth $163,326. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,128

Previous 10,428 50.82%

Holding current value

$163,326

Previous $465,000 53.12%

% of portfolio

0.03%

Previous 0.06%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 19, 2025	SELL	$37.92 - $45.7 $200,976 - $242,210	-5,300 Reduced 50.82%	5,128 $218,000
Q1 2025 May 14, 2025	BUY	$44.5 - $61.8 $16,954 - $23,545	381 Added 3.79%	10,428 $465,000
Q4 2024 Feb 14, 2025	BUY	$40.05 - $59.11 $49,181 - $72,587	1,228 Added 13.92%	10,047 $551,000
Q3 2024 Nov 14, 2024	SELL	$42.25 - $53.56 $37,729 - $47,829	-893 Reduced 9.19%	8,819 $372,000
Q2 2024 Aug 14, 2024	SELL	$41.71 - $52.9 $18,435 - $23,381	-442 Reduced 4.35%	9,712 $445,000
Q1 2024 May 13, 2024	SELL	$32.52 - $52.33 $47,576 - $76,558	-1,463 Reduced 12.59%	10,154 $528,000
Q4 2023 Feb 14, 2024	BUY	$30.85 - $37.09 $196,329 - $236,040	6,364 Added 121.15%	11,617 $413,000
Q3 2023 Nov 14, 2023	BUY	$31.69 - $39.25 $19,235 - $23,824	607 Added 13.07%	5,253 $176,000
Q2 2023 Aug 14, 2023	BUY	$29.0 - $38.37 $44,051 - $58,284	1,519 Added 48.58%	4,646 $174,000
Q1 2023 May 12, 2023	BUY	$23.85 - $31.34 $2,432 - $3,196	102 Added 3.37%	3,127 $91,000
Q4 2022 Feb 14, 2023	BUY	$17.65 - $27.37 $10,254 - $15,901	581 Added 23.77%	3,025 $79,000
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $8,052 - $11,584	356 Added 17.05%	2,444 $57,000
Q2 2022 Aug 15, 2022	BUY	$22.88 - $39.45 $47,773 - $82,371	2,088 New	2,088 $53,000

Others Institutions Holding VCEL

# of Institutions

295

Shares Held

54M

Call Options Held

35.6K

Put Options Held

7.7K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.5B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account